Lisa Ae Vlug

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Top Venues

JMIR human factors

This page only lists publications with an associated author ORCID identifier.

Publications

Liselot Nicoline van den Berg, Cynthia Hallensleben, Lisa Ae Vlug, Niels Henrik Chavannes, Anke Versluis
The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR human factors 11 (2024)
Liselot Nicoline van den Berg, Cynthia Hallensleben, Lisa Ae Vlug, Niels Henrik Chavannes, Anke Versluis
The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR human factors 11 (2024)
Liselot Nicoline van den Berg, Cynthia Hallensleben, Lisa Ae Vlug, Niels Henrik Chavannes, Anke Versluis
The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR human factors 11 (2024)
Liselot Nicoline van den Berg, Cynthia Hallensleben, Lisa Ae Vlug, Niels Henrik Chavannes, Anke Versluis
The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR human factors 11 (2024)
Liselot Nicoline van den Berg, Cynthia Hallensleben, Lisa Ae Vlug, Niels Henrik Chavannes, Anke Versluis
The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR human factors 11 (2024)
Liselot Nicoline van den Berg, Cynthia Hallensleben, Lisa Ae Vlug, Niels Henrik Chavannes, Anke Versluis
The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR human factors 11 (2024)